Cystic fibrosis
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
SAN DIEGO–(BUSINESS WIRE)–Feb 11, 2020– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of an agreement whereby Ligand will acquire the core assets of Icagen, Inc.’s North Carolina operations, including partnered programs, proprietary ion channel screening and assay platforms, x-ray fluorescence capabilities, custom screening technologies and novel unpartnered preclinical-stage molecules for $15 million in cash. …
Cystic fibrosis drug to be free on NHS in 30 days after US firm bows to pressure
A US drug company has bowed to pressure and agreed to supply a life-changing medicine on the NHS. Vertex was slammed by Jeremy Corbyn in his conference speech for refusing to drop its price for the cystic fibrosis drug Orkambi. The Labour leader vowed to change the way drugs were patented to stop big pharma …
